Edward Feener Net Worth & Insider Trades
Edward Feener - Chief Scientific Officer, Kalvista Pharmaceuticals, Inc
What is Edward Feener's Net Worth?
The current estimated net worth of Kalvista Pharmaceuticals, Inc's Chief Scientific Officer, Edward Feener, is estimated to be about $3.75M . Edward Feener owns about 66,771 units of Kalvista Pharmaceuticals, Inc common stock. In the last 6 years at Kalvista Pharmaceuticals, Inc, Edward Feener has sold an estimated value of $3.08M worth.
What is Edward Feener's Past Insider Trading?
Edward Feener's largest purchase order was 6,000 units , worth over $61.26K on May 6, 2021. Edward Feener's largest sale order was 31,000 units , worth over $1.04M on February 25, 2021. In total, Edward Feener has made about 25 transactions over 6 years of their time at Kalvista Pharmaceuticals, Inc. Edward Feener usually trades in May, with the busiest year in 2021. The most recent transaction was a sale order of 1,786 units , worth over $18.12K on May 19, 2023.
Edward Feener
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Edward Feener's' Mailing Address?
- Mailing address is One Kendall Square, Building 200 Suite 2203 Cambridge MA 02139 MA
Kalvista Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| T. Andrew Crockett | 2021 | $556,120 | $458,799 | - | $1,281,708 | $11,400 | $2,308,027 |
| T. Andrew Crockett | 2020 | $556,120 | $229,400 | - | $1,163,160 | $11,882 | $1,960,562 |
| T. Andrew Crockett | 2019 | $505,000 | $353,500 | - | $2,418,444 | $11,000 | $3,287,944 |
| Benjamin L. Palleiko | 2021 | $435,000 | $261,000 | - | $747,663 | $15,850 | $1,459,513 |
| Benjamin L. Palleiko | 2020 | $435,000 | $156,600 | - | $581,580 | $11,900 | $1,185,080 |
| Benjamin L. Palleiko | 2019 | $366,000 | $192,150 | $527,794 | $994,555 | $11,000 | $2,091,499 |
| Christopher M. Yea | 2021 | $420,000 | $252,000 | - | $712,060 | $25,341 | $1,409,401 |
| Christopher M. Yea | 2020 | $420,000 | $117,600 | - | $480,773 | $25,271 | $1,094,044 |
| Christopher M. Yea | 2019 | $341,093 | $174,596 | - | $891,350 | $20,466 | $1,427,505 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1348911/000119312521249158/d191826ddef14a.htm
What are Kalvista Pharmaceuticals, Inc's Past Insider Trades?
Kalvista Pharmaceuticals, Inc's most recent insider trade came on May 19, 2023 by Christopher Yea who sold 2,604 units worth $26.42K . In the last 6 years, insiders at Kalvista Pharmaceuticals, Inc have sold an estimated value of $75.98M and bought an estimated value of $44.2M worth of shares. Insider trading is most common in October, with the busiest year in 2021 and 2019. The most active traders at the company are Andrew Thomas Crockett, CEO, Christopher Yea, Chief Development Officer, and Edward Feener, Chief Scientific Officer .
KalVista Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||